kras mutation and glutathion Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation the Potential of Immunotherapy Targeting KRAS Mutant Cancers with
Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell KRAS Screening and Profiling Services KRAS mutation: from undruggable to druggable in cancer Signal Transduction and Targeted Therapy What should we know about the 'undruggable' target KRAS? MedChemExpress Targeting KRAS: from metabolic regulation to cancer treatment Molecular Cancer Springer Nature Link
Pay in 4 interest-free payments of $6.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




